Anti-tumour necrosis factor therapy for ankylosing spondylitis--unresolved issues.
Jois
R N
RN
Gaffney
K
K
Keat
A
A
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D006297:Health Services Accessibility; D006801:Humans; D018579:Patient Selection; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha